GenoMEL logo
 
 
  GenoMEL is an international research consortium coordinated by the University of Leeds.
  University of Leeds
  Home
  News
  Programme
  Membership
  Participants
  Physician Information
  Patient Information
  Papers
  Exchange Programme
  data sharing
  Knowledge Transfer
  Members Section
  Stage III Melanoma Research Group
  PharmacoGenoMEL
  Contact Us
  Site Map
  Media
  Search Site
  useful links
  View this site in other languages
  Accessibility
  Terms and Conditions
Privacy Statement
Participants
Riga, Latvia
 
Group Details Group Members Group Publications
 
Group Details
   

Publications

 
 

Pjanova D, Heisele O, Engele L, Desjatnikova I.
Tumour suppressor gene CDKN2A/p16 germline mutations in melanoma patients with additional cancer and cancer in their family history.
Acta Universitatis Latviensis. 2003, 662: 25-32.

 
 

Heisele O, Ferdats A, Engele L.
Melanoma associated antigens as additional markers of tumour progression.
J.Tumour Marker Oncology, 2000, 15: 147-153.

 
 

Heisele O, Ferdats A, Engele L, Rupais A, Desjatnikova I.
Melanoma associated antigens as markers for melanoma progression and efficiacy of immunotherapy.
Acta Medica Lithuania, 2002, Suppl. 9: 44-46.

 
 

Pjanova D, Heisele O, Engele L, Balkovska I, Desjatnikova I, Ignatovica V.
CDKN2A/ARF and CDK4 germline alterations in sporadic cutaneous malignant melanoma patients of Latvian population.
In press.

Click here to see a PDF of this publication

 

   
 
   
website design: NKD | email: info@NKD.org.uk | site: www.NKD.org.uk